rewards
-
.
- eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.china's plans to import indian drugs fail to enthuse indian pharmaceutical firms
.
.consider making a donation to support the coverage that shapes the face of berkeley.
.
.
http://lm360.us/Moldenhauer-brother-of-Bloschichak-from-Nagapattinam?Krafftgra=240 punditfact
-
.
featured programs
-
.